Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Pexidartinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,400Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daiichi Sankyo to Showcase TURALIO® at CTOS for Giant Cell Tumor
    Daiichi Sankyo to Showcase TURALIO® at CTOS for Giant Cell Tumor

    13 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241113520939/en

    BUSINESSWIRE
    13 Nov 2024
    Share Share
    Daiichi Sankyo Provides Update on CHMP Review of Pexidartinib, a CSF1R
    Daiichi Sankyo Provides Update on CHMP Review of Pexidartinib, a CSF1R

    29 Jun 2020

    // DAIICHISANKYO

    https://www.daiichisankyo.com/media_investors/media_relations/press_releases/detail/007158.html

    DAIICHISANKYO
    29 Jun 2020
    Share Share
    EMA recommends eight new medicines, refuses one
    EMA recommends eight new medicines, refuses one

    27 Jun 2020

    // Kari Oakes RAPS

    https://www.raps.org/news-and-articles/news-articles/2020/6/ema-recommends-eight-new-medicines-refuses-one

    Kari Oakes RAPS
    27 Jun 2020
    Share Share
    Daiichi Sankyo Provides Update on CHMP Review of Pexidartinib, a CSF1R Inhibitor
    Daiichi Sankyo Provides Update on CHMP Review of Pexidartinib, a CSF1R Inhibitor

    26 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200626005278/en

    BUSINESSWIRE
    26 Jun 2020
    Share Share
    Daiichi Sankyo's Turalio becomes first FDA-approved therapy for rare tumour
    Daiichi Sankyo's Turalio becomes first FDA-approved therapy for rare tumour

    06 Aug 2019

    // PHARMAFILE

    http://www.pharmafile.com/news/525725/daiichi-sankyos-turalio-becomes-first-fda-approved-therapy-rare-tumour

    PHARMAFILE
    06 Aug 2019
    Share Share
    Daiichi Sankyo scores landmark FDA OK for rare tumor drug albeit restrictions
    Daiichi Sankyo scores landmark FDA OK for rare tumor drug albeit restrictions

    06 Aug 2019

    // Amber Tong ENDPTS

    https://endpts.com/daiichi-sankyo-scores-fda-ok-for-rare-tumor-drug-albeit-with-restrictions/

    Amber Tong ENDPTS
    06 Aug 2019
    Share Share